DE69907921D1 - Salmonella typhi impfstoffzusammensetzungen - Google Patents

Salmonella typhi impfstoffzusammensetzungen

Info

Publication number
DE69907921D1
DE69907921D1 DE69907921T DE69907921T DE69907921D1 DE 69907921 D1 DE69907921 D1 DE 69907921D1 DE 69907921 T DE69907921 T DE 69907921T DE 69907921 T DE69907921 T DE 69907921T DE 69907921 D1 DE69907921 D1 DE 69907921D1
Authority
DE
Germany
Prior art keywords
vaccine compositions
salmonella typhi
typhi vaccine
salmonella
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69907921T
Other languages
English (en)
Other versions
DE69907921T2 (de
Inventor
Pascale Demil
Hondt Erik D
Hoecke Christian Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69907921(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9818910.3A external-priority patent/GB9818910D0/en
Priority claimed from GBGB9909080.5A external-priority patent/GB9909080D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE69907921D1 publication Critical patent/DE69907921D1/de
Application granted granted Critical
Publication of DE69907921T2 publication Critical patent/DE69907921T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69907921T 1998-08-28 1999-08-24 Salmonella typhi impfstoffzusammensetzungen Revoked DE69907921T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9818910.3A GB9818910D0 (en) 1998-08-28 1998-08-28 Novel formulation
GB9818910 1998-08-28
GBGB9909080.5A GB9909080D0 (en) 1999-04-20 1999-04-20 Novel formulations
GB9909080 1999-04-20
PCT/EP1999/006202 WO2000012129A2 (en) 1998-08-28 1999-08-24 Salmonella typhi vaccine compositions

Publications (2)

Publication Number Publication Date
DE69907921D1 true DE69907921D1 (de) 2003-06-18
DE69907921T2 DE69907921T2 (de) 2004-03-11

Family

ID=26314288

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907921T Revoked DE69907921T2 (de) 1998-08-28 1999-08-24 Salmonella typhi impfstoffzusammensetzungen

Country Status (11)

Country Link
EP (2) EP1285666A1 (de)
JP (1) JP2002525277A (de)
AR (1) AR023643A1 (de)
AT (1) ATE240118T1 (de)
AU (1) AU5739999A (de)
CA (1) CA2341703A1 (de)
DE (1) DE69907921T2 (de)
DK (1) DK1107787T3 (de)
ES (1) ES2193742T3 (de)
PT (1) PT1107787E (de)
WO (1) WO2000012129A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2828406B1 (fr) * 2001-08-08 2005-06-24 Aventis Pasteur Composition vaccinale bivalente havi
NZ575272A (en) 2006-09-07 2012-02-24 Glaxosmithkline Biolog Sa Inactivated poliovirus type 1, diptheria toxoid, tetanus toxoid and killed whole-cell Bordetella pertussis vaccine
KR20150054800A (ko) 2012-09-10 2015-05-20 글리코박신 아게 변형된 항원을 포함하는 생체접합체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
RU2111012C1 (ru) * 1997-04-15 1998-05-20 Вячеслав Леонидович Львов Вакцинный препарат для профилактики брюшного тифа

Also Published As

Publication number Publication date
ES2193742T3 (es) 2003-11-01
WO2000012129A2 (en) 2000-03-09
EP1285666A1 (de) 2003-02-26
PT1107787E (pt) 2003-07-31
AR023643A1 (es) 2002-09-04
EP1107787A2 (de) 2001-06-20
CA2341703A1 (en) 2000-03-09
DE69907921T2 (de) 2004-03-11
WO2000012129A3 (en) 2000-06-29
EP1107787B1 (de) 2003-05-14
DK1107787T3 (da) 2003-09-01
ATE240118T1 (de) 2003-05-15
AU5739999A (en) 2000-03-21
JP2002525277A (ja) 2002-08-13

Similar Documents

Publication Publication Date Title
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
NO20004758D0 (no) Vaksinesammensetning
ATE490327T1 (de) Impfstoffzusammensetzung
NO20026175L (no) Vaksinesammensetning
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
NO20006191D0 (no) Vaksine
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
DE69512827D1 (de) Wasserabweisende Zusammensetzungen
DE69900634T2 (de) Shampoozusammensetzungen
NO20003302L (no) Vaksine
ID19097A (id) Komposisi-komposisi oral
ATE469550T1 (de) Antiparasitäre zusammensetzungen
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
PT1139764E (pt) Composicao adjuvante
DE69935172D1 (de) Imidosilan Zusammensetzungen
ID17860A (id) Komposisi vaksin
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
DE69503224T2 (de) Interne trennmittelzusammensetzungen
HUP0005010A3 (en) Salmonella vaccine
FI20000776A0 (fi) Elintarvikeseos
PT1124567E (pt) Composicoes tamponadas para dialise
NO20005599D0 (no) Vaksine
ID29857A (id) Vaksin oral terhadap diare
ATE240118T1 (de) Salmonella typhi impfstoffzusammensetzungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation